GSA Capital Partners »

Neurogene shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $250k 11k 22.86

More positions owned by GSA Capital Partners

Accenture Plc Ireland Shs Class A (ACN)
Sprouts Fmrs Mkt (SFM)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Qorvo (QRVO)
EOG Resources (EOG)
Nuvation Bio Com Cl A (NUVB)
Jefferies Finl Group (JEF)
Frontier Communications Pare (FYBR)
Hldgs (UAL)
Informatica Com Cl A (INFA)
TJX Companies (TJX)
Vital Farms (VITL)
Apple (AAPL)

View all positions for GSA Capital Partners

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene